🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07181993
Active, not recruiting Observational

The Impact of PRISCUS Medication on Fall Risks

NCT07181993 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-09-01
Last updated
2025-09-19

Condition(s) studied

Fall Injury

Study summary

Purpose:

This study aims to validate the medication entries in the PRISCUS list-a German expert-based compilation of potentially inappropriate medications for older adults-and to identify additional medications that may pose a fall risk but are not yet included.

Study Design:

This is a retrospective observational study uses electronic health record data from a German research hospital. It includes over 900,000 patient records from multiple departments with a high incidence of falls, covering the period from 2016 to 2022. Statistical analyses, including chi-square tests and propensity score matching, will be employed to evaluate the relationship between medications and fall events.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * All patients across 20 clinical departments with highest fall incidence Exclusion Criteria: * Age \< 18yrs

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute for Medical Informatics | Charité Universitätsmedizin Berlin Berlin State of Berlin

More Charite University, Berlin, Germany trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07181993 on ClinicalTrials.gov ↗ ← All trials in Germany